Concentrix (CNXC)
(Delayed Data from NSDQ)
$66.78 USD
-1.34 (-1.97%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $66.87 +0.09 (0.13%) 7:58 PM ET
4-Sell of 5 4
A Value C Growth D Momentum B VGM
Income Statements
Fiscal Year end for Concentrix Corporation falls in the month of November .
All items in Millions except EPS data.
11/30/23 | 11/30/22 | 11/30/21 | 11/30/20 | 11/30/19 | |
---|---|---|---|---|---|
Sales | 7,115 | 6,324 | 5,587 | 4,720 | 4,708 |
Cost Of Goods | 4,537 | 4,067 | 3,618 | 3,058 | 2,959 |
Gross Profit | 2,578 | 2,257 | 1,969 | 1,662 | 1,748 |
Selling & Adminstrative & Depr. & Amort Expenses | 1,917 | 1,617 | 1,397 | 1,353 | 1,454 |
Income After Depreciation & Amortization | 661 | 640 | 572 | 309 | 294 |
Non-Operating Income | -52 | 35 | 6 | 7 | 2 |
Interest Expense | 201 | 70 | 23 | 48 | 92 |
Pretax Income | 408 | 605 | 556 | 268 | 204 |
Income Taxes | 94 | 169 | 150 | 103 | 87 |
Minority Interest | 0 | 1 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 314 | 436 | 406 | 165 | 117 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 314 | 435 | 406 | 165 | 117 |
Depreciation Footnote | 11/30/23 | 11/30/22 | 11/30/21 | 11/30/20 | 11/30/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 1,056 | 950 | 850 | 585 | 600 |
Depreciation & Amortization (Cash Flow) | 394 | 310 | 277 | 277 | 306 |
Income After Depreciation & Amortization | 661 | 640 | 572 | 309 | 294 |
Earnings Per Share Data | 11/30/23 | 11/30/22 | 11/30/21 | 11/30/20 | 11/30/19 |
---|---|---|---|---|---|
Average Shares | 54.01 | 51.74 | 51.91 | 51.60 | NA |
Diluted EPS Before Non-Recurring Items | 10.58 | 11.11 | 9.58 | 5.89 | NA |
Diluted Net EPS (GAAP) | 5.70 | 8.28 | 7.70 | 3.19 | NA |
Fiscal Year end for Concentrix Corporation falls in the month of November .
All items in Millions except EPS data.
5/31/24 | 2/29/24 | 11/30/23 | 8/31/23 | 5/31/23 | |
---|---|---|---|---|---|
Sales | 2,380.72 | 2,402.75 | 2,230.76 | 1,632.83 | 1,614.71 |
Cost Of Goods | 1,523.15 | 1,546.22 | 1,407.91 | 1,039.14 | 1,034.48 |
Gross Profit | 857.57 | 856.53 | 822.86 | 593.69 | 580.23 |
SG&A, R&D, and Dept/Amort Expenses | 707.40 | 708.09 | 642.41 | 431.43 | 417.66 |
Income After SG&A, R&D, and Dept/Amort Expenses | 150.17 | 148.44 | 180.45 | 162.26 | 162.57 |
Non-Operating Income | 19.42 | 6.82 | -32.83 | -6.17 | -9.38 |
Interest Expense | 82.46 | 82.44 | 70.51 | 49.29 | 47.21 |
Pretax Income | 87.13 | 72.82 | 77.11 | 106.81 | 105.97 |
Income Taxes | 20.29 | 20.72 | 7.62 | 29.17 | 27.12 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 66.83 | 52.10 | 69.49 | 77.64 | 78.85 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 66.83 | 52.10 | 69.49 | 77.64 | 78.85 |
Earnings Per Share Data | 5/31/24 | 2/29/24 | 11/30/23 | 8/31/23 | 5/31/23 |
---|---|---|---|---|---|
Average Shares | 65.33 | 65.79 | 61.96 | 51.21 | 51.39 |
Diluted EPS Before Non-Recurring Items | 2.44 | 2.33 | 3.07 | 2.54 | 2.50 |
Diluted Net EPS (GAAP) | 0.98 | 0.76 | 1.02 | 1.49 | 1.51 |